vimarsana.com
Home
Live Updates
Gilead Sciences - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis : vimarsana.com
Gilead Sciences - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
FOSTER CITY - Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with...
Related Keywords
United Kingdom
,
Foster City
,
California
,
United States
,
Washington
,
Merdad Parsey
,
Jacquie Ross
,
Meaghan Smith
,
Gilead Company
,
Cymabay Therapeutics Inc
,
Gilead Sciences In Liver Disease
,
Gilead Sciences
,
Regulatory Agency
,
Nasdaq
,
Gilead Sciences Inc
,
University Of Miami
,
Exchange Commission
,
Drug Administration
,
European Medicines Agency
,
Bay Therapeutics
,
Presidential Plenary
,
Digestive Disease Week
,
Chief Medical Officer
,
New Drug Application
,
Child Pugh
,
Kingdom Medicines
,
Medicines Agency
,
Primary Biliary Cholangitis
,
Interim Results
,
Private Securities Litigation Reform Act
,
Quarterly Report
,
News Publishing
,
vimarsana.com © 2020. All Rights Reserved.